Evolving role of MeCP2 in Rett syndrome and autism

Janine M LaSalle, Dag H. Yasui

Research output: Contribution to journalArticle

72 Scopus citations

Abstract

Rett syndrome is an X-linked autism-spectrum disorder caused by mutations in MECP2, encoding methyl CpG-binding protein 2. Since the discovery of MECP2 mutations as the genetic cause of Rett syndrome, the understanding of MeCP2 function has evolved. Although MeCP2 was predicted to be a global transcriptional repressor of methylated promoters, large-scale combined epigenomic approaches of MeCP2 binding, methylation and gene expression have demonstrated that MeCP2 binds preferentially to intergenic and intronic regions, and sparsely methylated promoters of active genes. This review compares the evolution of thought within two 'classic' epigenetic mechanisms of parental imprinting and X chromosome inactivation to that of the MeCP2 field, and considers the future relevance of integrated epigenomic databases to understanding autism and Rett syndrome.

Original languageEnglish (US)
Pages (from-to)119-130
Number of pages12
JournalEpigenomics
Volume1
Issue number1
DOIs
StatePublished - Oct 2009

Keywords

  • Autism
  • Chromatin
  • Epigenetic
  • Imprinting
  • MeCP2
  • Methylation
  • Rett syndrome
  • X chromosome inactivation

ASJC Scopus subject areas

  • Genetics
  • Cancer Research

Fingerprint Dive into the research topics of 'Evolving role of MeCP2 in Rett syndrome and autism'. Together they form a unique fingerprint.

  • Cite this